Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,Pharmacology
Reference25 articles.
1. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes–2019;American Diabetes Association;Diabetes Care,2019
2. Is insulin the preferred treatment for HbA1c >9%?;Bloomgarden;J. Diabetes,2017
3. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes;Buse;Diabetes Care,2009
4. The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: Comparing the durability of lispro mix 75/25 and glargine;Buse;Diabetes Care,2011
5. Secondary failure rates associated with Metformin and sulphonylurea therapy for T2DM patients;Eurich;Pharmacotherapy,2005
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insulin therapy for elderly patients with type 2 diabetes mellitus;Meditsinskiy sovet = Medical Council;2024-05-08
2. Association of Hepcidin levels in Type 2 Diabetes Mellitus treated with metformin or combined anti-diabetic agents in Pakistani population;Journal of the Pakistan Medical Association;2022-11-01
3. CLINICAL EFFECTIVENESS OF FIXED DOSE COMBINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN (EMPA/LINA) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS UNWILLING TO CONTINUE BASAL INSULIN THERAPY: A REAL-WORLD EXPERIENCE IN INDIAN SETTING;INDIAN JOURNAL OF APPLIED RESEARCH;2021-10-01
4. Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis;Scientific Reports;2021-02-18
5. Type 2 diabetes mellitus in Saudi Arabia: A review of the current situation;Journal of Diabetology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3